Prospection of immunological biomarkers for characterization and monitoring of asymptomatic


Journal

Parasitology
ISSN: 1469-8161
Titre abrégé: Parasitology
Pays: England
ID NLM: 0401121

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 29 5 2020
medline: 10 4 2021
entrez: 29 5 2020
Statut: ppublish

Résumé

In areas endemic for Leishmania infantum, an asymptomatic infection may be an indicator of the extent of transmission. The main goal of this study was to evaluate the applicability of measuring circulating immunological biomarkers as an alternative strategy to characterize and monitor L. infantum asymptomatic infections in combination with serological methods. To this end, 179 children from a region endemic for visceral leishmaniasis (VL), aged 1-10 years old, selected from a cross-sectional study, were identified as asymptomatic (n = 81) or uninfected (n = 98) by qPCR and/or serological tests (ELISA using L. infantum soluble antigen and rK39), and, together with serum samples of children diagnosed with VL (n = 43), were subjected to avidity tests and cytokine levels measurement. Avidity rates (AR) ranging from 41 to 70% were found in 29 children (66%) from the asymptomatic group. On the other hand, high AR (above 70%) were observed in 27 children (64%) from the VL group. Logistic Regression and Classification and Regression Tree (CART) analyses demonstrated that lower AR and IFN-γ production associated with higher IL-17A levels were hallmarks in asymptomatic L. infantum infections. Therefore, this study proposes an association of immunological biomarkers that can be used as a complementary strategy for the characterization and monitoring of asymptomatic VL infections in children living in endemic areas.

Identifiants

pubmed: 32460936
doi: 10.1017/S0031182020000852
pii: S0031182020000852
pmc: PMC10317783
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1124-1132

Références

Trans R Soc Trop Med Hyg. 1999 Sep-Oct;93(5):464
pubmed: 10696398
PLoS Negl Trop Dis. 2019 Jul 1;13(7):e0007493
pubmed: 31260440
Clin Infect Dis. 2000 Mar;30(3):608-9
pubmed: 10722458
Clin Vaccine Immunol. 2013 Nov;20(11):1697-702
pubmed: 24006136
PLoS Negl Trop Dis. 2012;6(12):e1955
pubmed: 23272263
Pathog Glob Health. 2013 Mar;107(2):78-87
pubmed: 23683334
PLoS Negl Trop Dis. 2009 Oct 20;3(10):e536
pubmed: 19841736
Rev Soc Bras Med Trop. 2005 Mar-Apr;38(2):137-41
pubmed: 15821787
Am J Trop Med Hyg. 2002 Oct;67(4):344-8
pubmed: 12452487
Am J Trop Med Hyg. 2002 Apr;66(4):334-7
pubmed: 12164285
PLoS One. 2012;7(5):e35671
pubmed: 22693548
J Virol Methods. 1996 Feb;56(2):125-37
pubmed: 8882643
Parasit Vectors. 2018 Nov 12;11(1):586
pubmed: 30419944
Am J Trop Med Hyg. 1983 Sep;32(5):943-6
pubmed: 6353959
PLoS Negl Trop Dis. 2010 Jan 19;4(1):e584
pubmed: 20098726
Clin Diagn Lab Immunol. 2002 May;9(3):568-72
pubmed: 11986261
Rev Soc Bras Med Trop. 2006 Sep-Oct;39(5):421-7
pubmed: 17160317
Clin Exp Immunol. 1984 Apr;56(1):58-66
pubmed: 6424987
Scand J Immunol. 2005 Nov;62(5):487-95
pubmed: 16305646
J Clin Invest. 2009 Aug;119(8):2379-87
pubmed: 19620772
Am J Trop Med Hyg. 2001 Nov;65(5):583-7
pubmed: 11716118
PLoS One. 2015 Nov 11;10(11):e0141700
pubmed: 26558622
Braz J Infect Dis. 2009 Feb;13(1):44-6
pubmed: 19578629
Am J Trop Med Hyg. 2018 Mar;98(3):875-882
pubmed: 29280433
J Infect Dis. 1996 Mar;173(3):758-61
pubmed: 8627048
Clin Vaccine Immunol. 2006 Aug;13(8):969-71
pubmed: 16894000
Rev Soc Bras Med Trop. 2001 Sep-Oct;34(5):445-51
pubmed: 11600910
J Infect Dis. 1986 Dec;154(6):1003-11
pubmed: 3782864
Mem Inst Oswaldo Cruz. 2012 Sep;107(6):735-9
pubmed: 22990961
Ann Ist Super Sanita. 2004;40(1):71-80
pubmed: 15269455
Clin Exp Immunol. 2006 Oct;146(1):124-32
pubmed: 16968407
PLoS Negl Trop Dis. 2016 Jan 27;10(1):e0004375
pubmed: 26814478
Trans R Soc Trop Med Hyg. 2008 Jun;102(6):548-55
pubmed: 18367221
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):775-9
pubmed: 8421715
Front Immunol. 2017 Sep 29;8:1208
pubmed: 29033933
J Infect Dis. 1992 Nov;166(5):1124-32
pubmed: 1402024
Mol Biochem Parasitol. 1992 Mar;51(1):133-42
pubmed: 1565128

Auteurs

Gisele Macêdo Rodrigues da Cunha (GMR)

Laboratório de Epidemiologia de Doenças Infecciosas e Parasitárias, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901, Belo Horizonte, MG, Brazil.

Mariângela Carneiro (M)

Laboratório de Epidemiologia de Doenças Infecciosas e Parasitárias, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901, Belo Horizonte, MG, Brazil.
Pós-graduação em Ciências da Saúde, Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Brazil.

Marcelo Antônio Pascoal-Xavier (MA)

Grupo Imunologia de Doenças Virais, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), 30190-002, Belo Horizonte, MG, Brazil.
Laboratório de Patologia Molecular, Departamento de Anatomia Patológica, Faculdade de Medicina, Universidade Federal de Minas Gerais, 30130-100, Belo Horizonte, MG, Brazil.

Iara Caixeta Marques da Rocha (ICM)

Laboratório de Epidemiologia de Doenças Infecciosas e Parasitárias, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901, Belo Horizonte, MG, Brazil.

Fernanda do Carmo Magalhães (FDC)

Laboratório de Epidemiologia de Doenças Infecciosas e Parasitárias, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901, Belo Horizonte, MG, Brazil.

Olindo Assis Martins-Filho (OA)

Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), 30190-002, Belo Horizonte, MG, Brazil.

Edward Oliveira (E)

Pesquisa Clínica e Políticas Públicas em Doenças Infecciosas e Parasitárias, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), 30190-002, Belo Horizonte, MG, Brazil.

Vanessa Peruhype-Magalhães (V)

Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), 30190-002, Belo Horizonte, MG, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH